Introduction
Highly active antiretroviral therapy (HAART) has led to a dramatic decline in mortality among people living with human immunodeficiency virus (HIV) infection (PLWH) or acquired immune deficiency syndrome (AIDS) (1), with improved life expectancy approaching that of the general population (2) . As a large multinational study from prior to 1995 to 2006 indicated, the excess mortality rate among HIV-infected individuals decreased from 40.8 to 6.1 per 1000 person-years (3).
In the current HAART era, AIDS is more like a chronic manageable disease rather than a rapidly progressing and fatal one (2) . Therefore, the focus of HIV/AIDS care has been shifting from inpatient medical treatment to outpatient-based chronic disease management. However, the hospitalization rate and inpatient mortality rate remained higher in PLWH despite increasing accessibility to HAART in comparison to either the general population or HIV-negative individuals (4) (5) (6) .
Deaths among HIV-infected inpatients during the HAART era need to be characterized in order to formulate intervention strategies to improve medical care and further reduce mortality in this population. Recent studies examining deaths of HIV-infected inpatients in the United States revealed that the in-hospital mortality rate declined significantly and that major causes of deaths had shifted to non-AIDS-related diseases (4, 7) . In settings with limited medical resources such as subSaharan Africa, the in-hospital mortality rate among HIVinfected adults remained high and AIDS-related illnesses still caused most deaths (8) . To the extent known, the mortality trends or the causes of death among Chinese HIV-infected inpatients have seldom been reported during the HAART era. The current study retrospectively reviewed the outcomes, calculated the mortality, and analyzed the causes of death in HIV-infected inpatients at a medical center for HIV infection and AIDS in Shanghai over the past decade (2006-2015).
Materials and Methods

Subjects
This study was conducted at the Shanghai Clinical Center for Public Health (SCCPH), a tertiary care hospital affiliated with Fudan University. The SCCPH is the only designated medical institution that has provided outpatient and inpatient care for PLWH in Shanghai since the 1990s. Currently, about 6,000 HIV-infected patients in Shanghai are being regularly followed by the SCCPH. In 2015, more than 1,300 HIV-infected patients were admitted for AIDS or non-AIDS-related illnesses. All deaths of HIV-infected inpatients at the SCCPH from January 1, 2006 to December 31, 2015 were retrospectively reviewed. This study was approved by ethics committee of the SCCPH.
Data collection
A standardized data collection tool was used to abstract demographic characteristics (i.e. age, gender, duration of hospital stay), medical comorbidities besides AIDSrelated diseases (cardio-cerebrovascular disease including hypertension, congestive heart failure, myocardial infarction, and stroke; diabetes mellitus; pulmonary disease including chronic obstructive pulmonary disease and asthma; liver disease including chronic hepatitis B or C and liver cirrhosis; kidney dysfunction defined by serum creatinine > 1.5 mg/dL; and anemia defined as hemoglobin < 100 g/L; thrombocytopenia defined as a blood platelet count < 100 × 10 9 /L), a history of HAART administration, and the CD4+ T cell count on admission.
Two HIV-trained clinicians independently identified the causes of deaths based on clinical, laboratory, radiological, and microbiologic data through a comprehensive review of medical records. If there was disagreement over the cause of death, the final determination was made by consensus between the two clinicians. The causes of deaths were classified as AIDS-related or non-AIDS-related illnesses based on published definitions. Death caused by one of the Centers for Disease Control and Prevention (CDC) category C diseases was defined as AIDS-related death (9, 10) . Non-AIDS illnesses included non-AIDS infections, cardiovascular disease, liver disease, non-AIDS malignancy, renal disease, gastrointestinal hemorrhage, and trauma. Infectious etiologies not on the list of AIDS-defining conditions were classified as non-AIDS infection, e.g. sepsis and non-recurrent bacterial pneumonia (4). Cardiovascular disease was deemed to cause death if patients had one of the following clinical manifestations: cardiac arrest, ischemic or hemorrhagic stroke, congestive heart failure, myocardial infarction, or cardiac arrhythmia. Death from liver disease was deemed to occur when one of the following manifestations occurred with underlying liver disease: coagulopathy, bleeding esophageal varices, hepatic encephalopathy, hepatorenal syndrome, or spontaneous bacterial peritonitis. Death from renal disease was defined as death from primary renal failure. Deaths caused by gastrointestinal bleeding without underlying liver disease were attributed to gastrointestinal hemorrhage.
Statistical analysis
Statistical analysis was performed using SPSS version 19.0 for Windows. Overall or yearly mortality rates were calculated as the percentage of deaths overall or yearly among patients who were diagnosed with an HIV infection or AIDS and discharged (4, 7) . The chisquared test was used to compare categorical variables, and group comparisons of quantitative variables were performed using a parametric (analysis of variance) or nonparametric technique (Wilcoxon test) in accordance with the distribution of the variable. Bivariate analysis was used to determine factors associated with AIDS versus non-AIDS-related deaths in the cohort.
Results
Mortality among HIV-infected inpatients
In total, there were 326 in-hospital deaths among 6,473 HIV-infected patients discharged from the SCCPH from 2006 to 2015 ( Figure 1) , with an overall mortality rate of 5.04% (326/6,473). Notably, the mortality rate among HIV-infected inpatients (χ 2 = 34.41, p < 0.001) tended to decline during this period, in which the yearly inpatient mortality rates were 12.33% (9/73), 
Analysis of causes of death
Out of 326 deaths of HIV-infected patients, 23 lacked medical information integral to the assessment of the cause of death, so those deaths were excluded from further analysis ( Figure 1 ). The remaining 303 deaths were included in the all-cause mortality analysis, and the demographic and clinical characteristics of these deaths are summarized in Table 1 . The vast majority Table 2 . Major causes of death were AIDS-related illnesses (76.9%, 233/303), with Pneumocystis pneumonia (PCP) (26.4 %, 80/303) and recurrent bacterial pneumonia (10.2%, 31/303) as the two most common causes followed by nontuberculous mycobacteria (NTM) or Mycobacterium tuberculosis (MTB) infection (18.5%, 56/303), and AIDS-related encephalopathy (15.5%, 47/303) including progressive multifocal leukoencephalopathy, cryptococcal meningitis, cerebral toxoplasmosis, and CMV encephalitis. Other less frequent AIDS-related causes of death were AIDSrelated malignancy (5.9%, 18/303) (i.e. Kaposi sarcoma and non-Hodgkin's lymphoma) and wasting syndrome due to AIDS (0.4%, 1/303). A point worth noting is that non-AIDS-related illnesses caused roughly 1/4 (23.1%, 70/303) of the inpatient deaths at the SCCPH. Sepsis (5.9%, 18/303) and liver diseases (3.6%, 11/303) were the two major non-AIDS-related causes of death. Other common causes were non-recurrent bacterial pneumonia (3%, 9/303), gastrointestinal hemorrhage (2.6%, 8/303), non-AIDS-related malignancy (2.3%, 7/303), cardiovascular disease (2%, 6/303), renal disease (1.7%, 5/303), and trauma (0.7%, 2/303). The remaining non-AIDS-related deaths was caused by other comorbidities (1.3%, 4/303) such as bacterial meningitis, acute myelitis, a neurological disorder, and malaria. As shown in Figure 3 , the proportion of AIDS-related or non-AIDSrelated deaths did not change significantly over time (χ 2 = 13.847, p = 0.127).
Characteristic factors associated with AIDS-related or non-AIDS-related deaths
Compared to patients who died from non-AIDS-related illness, patients who died from AIDS were younger (median age: 47 vs. 51 years, p = 0.017), they had a lower CD4+ T cell count (median 17 vs. 69 cells/μL, p < 0.001), and they were less likely to be receiving HAART (16.3% vs. 34.3%, p = 0.001) on admission. In contrast, comorbidities on admission including kidney dysfunction (27.1% vs. 3.9%, p < 0.001), cardia-cerebrovascular disease (21.4% vs. 6.9%, p < 0.001), diabetes mellitus (15.7% vs. 5.2%, p = 0.003), anemia (51.4% vs. 27.9%, p < 0.001), thrombocytopenia (35.7% vs. 20.2%, p = 0.007), and liver disease (24.3% vs. 14.2%, p = 0.045) were more common among non-AIDS-related deaths ( Table 3) .
The factors associated with the cause of death were further analyzed using multivariate logistic regression (Table 3) . Factors including a CD4+ T cell count < 50 cells/μL (OR: 4.587; 95% CI: 2.387-8.815) and fewer comorbidities such as liver (OR: 0.402; 95% CI: 0.182-0.886) and kidney comorbidities (OR: 0.192; 95% CI: 0.069-0.535) on admission were independently associated with AIDS-related deaths.
Discussion
A comprehensive awareness of the deaths among HIV-infected inpatients is believed to be essential to improving the outcomes and quality of medical care provided by medical personnel. However, a nationwide study of the details of deaths among HIVinfected inpatients in China still needs to be conducted. The current study investigated the mortality rate, the underlying causes, and the possible factors correlated with different causes of death among HIV-infected inpatients at the SCCPH. Since the SCCPH is the most influential medical center for HIV/AIDS patient care in Eastern China, the findings of this study may partially depict the outcomes for HIV-infected patients admitted for inpatient care during the HAART era in China, and especially those with access to vast medical resources.
Results revealed an overall mortality rate of 5.04% for HIV-infected inpatients at the SCCPH from 2006 to 2015. This rate was higher than that reported in Western countries during the HAART era (2-3%) (4,5), but it was significantly lower than that reported in sub-Saharan Africa (8) . Therefore, this difference presumably reflects an association between socio-economic status and the outcomes of HIV infection to some extent.
Importantly, a marked decline in the yearly mortality rate (from 12.33% in 2006 to 3.2% in 2015) among HIV-infected inpatients was noted in the current study, and a similar trend has been noted in the West. There are several potential explanations for this trend. First and foremost, increased accessibility to HAART due to promotion of the National Free Antiretroviral Therapy Program (NFATP) since 2004 has been crucial to improving outcomes for HIV-infected inpatients (11, 12) . Second, the efforts of both government and social groups have raised public awareness of HIV infection over the last decade (13) and the coverage of HIV screening and surveillance has expanded, especially among high-risk populations. One recent study found that testing for HIV increased more than two-fold among men who have sex with men (MSM) from 2008 to 2012 in Nanjing, the capital of Jiangsu Province in Eastern China, while testing programs for MSM were promoted (14) . Moreover, the SCCPH is the designated medical facility providing inpatient care for HIV-infected patients in Shanghai and Eastern China, so medical personnel at the SCCPH have gained experience managing HIV infection and AIDS-related illnesses. This may explain why the survival of HIVinfected inpatients has improved during the HAART era, as a study previously reported (15) .
The current results revealed that the deaths of HIVinfected patients admitted to the SCCPH were mainly caused by AIDS-related illnesses. Results also revealed no significant change in the proportion of causes of death due to AIDS or non-AIDS-related illnesses over the last decade. Similar results were reported in another study investigating outcomes for HIV-infected patients after discharge from a hospital in Beijing, the capital of China (16). However, the major causes of death among HIVinfected inpatients in Western countries have shifted to non-AIDS-related illnesses during the HAART era, and the proportion of non-AIDS-related deaths has increased over time (4, 7) . These differences might be correlated with the current status of the HIV epidemic in China. A cross-sectional study conducted in 10 provinces of mainland China from 2009 to 2010 revealed that more than 70% of newly diagnosed cases of HIV infection were categorized as late presentation (defined as a CD4 count ≤ 200 cells/μL at HIV diagnosis), and the study found that late presentation was associated with increased AIDS-related morbidity and mortality (17) . Similarly, another recent study also reported that most Chinese HIV-infected patients (72.6%) had a concurrent AIDS diagnosis at the time of HIV diagnosis or developed AIDS within 1 year after HIV diagnosis (18) . In contrast, studies conducted in the West reported that no more than 30% of HIV-infected individuals presented with CD4+ T cells < 200/μL (19) . The current study also found that most deceased HIV-infected inpatients, and especially those who died of AIDS-related illnesses, had a low CD4+ T cell count (< 50 cell/μL) and were not receiving HAART when admitted. These factors are the two biggest risk factors for developing AIDSrelated illnesses such as opportunistic infections and malignancies (20, 21) . Despite the increasing (4, 7) , the current results revealed that a lower CD4+ T cell count (< 50/μL) was a characteristic of mortality due to AIDS-related illness, and liver or kidney comorbidities on admission were more common in patients who died of non-AIDS-related illnesses. Consequently, the current study has highlighted the need for physicians to pay closer attention to these clinical features and the need to optimize decision-making accordingly.
Admittedly, this study had several limitations. First, it was an observational and retrospective study, so the possibility of bias in assigning causes of death by reviewing medical records cannot be ruled out. Second, this study did not include a proper control group such as HIV-infected inpatients who survived or HIV-negative inpatients who died in hospital, which would otherwise substantiate the current conclusions. The findings of this study may not fully depict the overall outcomes for HIV-infected inpatients in China, and especially those in regions with different socioeconomic levels and medical resources. Further prospective studies involving HIV-infected inpatients at multiple centers need to be conducted in order to better ascertain the outcomes for and characteristics of these patients in China during the HAART era.
Conclusion
Although the yearly overall mortality rate among HIVinfected inpatients tended to decline, this study found that the major causes of deaths were attributed to AIDSrelated illnesses over the past decade. In light of those circumstances, further efforts are needed to improve HIV surveillance and AIDS care in China.
